NsGene A/S

🗓 Founded 1999👥 13 employees
Biotechnology Research🌐 nsgene.dk
Website LinkedIn
NsGene is committed to developing novel biological products for the treatment of neurological diseases and is focusing on Alzheimer’s disease, Parkinsons disease and sensorineural hearing loss. NsGene is developing unique treatment options based on the proprietary technology EC Biodelivery(TM), an advanced platform for delivery of therapeutic macromolecules behind the blood-brain-barrier, into the cochlea, or at other sites difficult to reach by conventional drug delivery methods.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was NsGene A/S founded?
NsGene A/S was founded in 1999.
What industry is NsGene A/S in?
NsGene A/S operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.